Literature DB >> 35590115

Gonococcal arthritis: case series of 58 hospital cases.

Aurore Moussiegt1, Claire François2, Olivier Belmonte3, Julien Jaubert4, Nicolas Traversier3, Sandrine Picot4, Françoise Josse5, Xavier Guillot1, Patrice Poubeau6, Marie-Pierre Moiton7, Antoine Bertolotti6,8, Loïc Raffray9,10,11.   

Abstract

OBJECTIVES: Extra-genital manifestations of gonococcal infection are rare (0.5-3%). Among them, gonococcal arthritis (GA) is the most frequent, accounting for 30-90% of disseminated infections. Our study aimed to describe all hospital cases of GA in Reunion Island, a French overseas territory.
METHODS: We conducted a retrospective, multicentric, observational study of all cases of certain, probable or possible GA from 2008 to 2020.
RESULTS: We identified 58 cases of GA, mostly certain cases (n = 48). Sex ratio was balanced, but men were older than women (51 vs 27 years, p < 0.001). A total of 41% had travelled abroad during the previous 3 months, mostly in Madagascar or South-East Asia. The most frequently infected joint was the knee, followed by ankle, wrist and fingers or carpal joints. Only 16% of cases had genital symptoms, but 50% had another extra-genital manifestation, mainly skin lesions (40%). Positivity rate of joint puncture was 91%, with a purulent liquid. Only 58% had a positive culture, and 33% had only a positive PCR. There was no 3GC-resistant strain. In comparison with gonococcal infection without arthritis, patients were older and had fewer genital but more extra-genital symptoms. On discharge 60% had persistent articular symptoms. GA represented 18% of all hospitalised septic arthritis cases with microbial identification in 2019.
CONCLUSIONS: GA is rare but it is important to make an early diagnosis and treat promptly, as joint destruction may be important, leading to persistent symptoms after discharge. PCR use in joint puncture is useful in cases with negative culture.
© 2022. The Author(s), under exclusive licence to International League of Associations for Rheumatology (ILAR).

Entities:  

Keywords:  Bacterial arthritis; Gonococcus; Neisseria gonorrhoeae; Tenosynovitis

Mesh:

Year:  2022        PMID: 35590115     DOI: 10.1007/s10067-022-06208-w

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   3.650


  8 in total

1.  The emerging threat of untreatable gonococcal infection.

Authors:  Gail A Bolan; P Frederick Sparling; Judith N Wasserheit
Journal:  N Engl J Med       Date:  2012-02-09       Impact factor: 91.245

Review 2.  Gonococcal arthritis (disseminated gonococcal infection).

Authors:  Peter A Rice
Journal:  Infect Dis Clin North Am       Date:  2005-12       Impact factor: 5.982

3.  Antimicrobial Resistance in Neisseria gonorrhoeae and Treatment of Gonorrhea.

Authors:  Magnus Unemo; Daniel Golparian; David W Eyre
Journal:  Methods Mol Biol       Date:  2019

Review 4.  Disseminated gonococcal infection (DGI) and gonococcal arthritis (GCA): I. Bacteriology, epidemiology, host factors, pathogen factors, and pathology.

Authors:  B I Eisenstein; A T Masi
Journal:  Semin Arthritis Rheum       Date:  1981-02       Impact factor: 5.532

Review 5.  Gonococcal arthritis.

Authors:  Thomas Bardin
Journal:  Best Pract Res Clin Rheumatol       Date:  2003-04       Impact factor: 4.098

Review 6.  Disseminated gonococcal infection (DGI) and gonococcal arthritis (GCA): II. Clinical manifestations, diagnosis, complications, treatment, and prevention.

Authors:  A T Masi; B I Eisenstein
Journal:  Semin Arthritis Rheum       Date:  1981-02       Impact factor: 5.532

7.  Strain characteristics and antibiotic susceptibility of isolates of Neisseria gonorrhoeae causing disseminated gonococcal infection in Australia. Members of the Australian Gonococcal Surveillance Programme.

Authors:  J W Tapsall; E A Phillips; T R Shultz; B Way; K Withnall
Journal:  Int J STD AIDS       Date:  1992 Jul-Aug       Impact factor: 1.359

8.  Innate recognition by neutrophil granulocytes differs between Neisseria gonorrhoeae strains causing local or disseminating infections.

Authors:  Alexandra Roth; Corinna Mattheis; Petra Muenzner; Magnus Unemo; Christof R Hauck
Journal:  Infect Immun       Date:  2013-04-29       Impact factor: 3.441

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.